Speech-Language Pathologists in Benton, AR Accepting Medicare

110 Speech-Language Pathologists found. Showing 101 - 110

Mrs. Elizabeth K. Boschetti, MA,CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 Interstate 30, Suite 3, Benton, AR 72019 Phone: 501-315-4414    Fax: 501-315-3467

Aaron Bean, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2909 Silverton Dr, Benton, AR 72019 Phone: 501-351-0740

Mary Barber, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 Interstate 30 N Ste 3, Benton, AR 72019 Phone: 501-315-4414

Kelly Jo Benson, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 I-30 Ste 3, Benton, AR 72019 Phone: 501-315-4414    Fax: 501-315-3467

Mrs. Laura Lynn Shotts, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 I 30, Suite 3, Benton, AR 72015 Phone: 501-315-4414    Fax: 501-315-3467

Autumn P Pride, MS, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 I-30 Ste 3, Benton, AR 72019 Phone: 501-315-4414    Fax: 501-315-3467

Mrs. Sarah Wilkinson Allen, MCD CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 I 30, Ste 3, Benton, AR 72015 Phone: 501-315-4414    Fax: 501-315-3467

Lauren Renee Bass Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 Interstate 30 N Ste 3, Benton, AR 72019 Phone: 501-315-4414

Anna Katherine Hill, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17706 Interstate 30 N Ste 3, Benton, AR 72019 Phone: 501-315-4414

Mrs. Regina S Kelley, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 121 Cox St, Benton, AR 72015 Phone: 501-776-0691    Fax: 501-776-0692

News Archive

Scientists create fluorescent proteins for live cell imaging, biosensor design

Scientists at Carnegie Mellon University's Molecular Biosensor and Imaging Center have developed new "fluorogen activating proteins" (FAPs) that will become a key component of novel molecular biosensor technology being created at Carnegie Mellon.

Tibotec to present results of TMC435 phase 2b study on HCV at AASLD 2011

Tibotec Pharmaceuticals (Tibotec), one of the Janssen (Janssen) Pharmaceutical Companies, today will present results of the final analysis of PILLAR, a phase 2b study of the investigational hepatitis C virus (HCV) NS3/4A protease inhibitor TMC435 in treatment-naïve patients with chronic genotype 1 HCV, as part of a late-breaker oral presentation at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, CA, USA.

Biotheranostics launches complete genomic tests for metastatic cancer patients

bioTheranostics, Inc., today introduced the bioT3 Metastatic Cancer Solution, a suite of genomic-based tests that provide personalized diagnostic information and therapeutic guidance for metastatic cancer patients across the continuum of care.

EMP levels may help clinicians diagnose early emphysema

Monitoring blood for tiny particles released by cells lining the lungs may help clinicians diagnose emphysema in its earliest stages, according to researchers from Weill Cornell Medical College. The particles, called endothelial microparticles, are shed during the disease process as tiny blood vessels in the lungs, called pulmonary capillaries, are injured and die.

Meaningful legislation required to control biotech medicine cost, says PCMA

"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3
• 4
• 5
• 6(current)